Kentucky 2026 Regular Session

Kentucky House Bill HB156

Introduced
1/7/26  
Refer
1/7/26  

Caption

AN ACT relating to intranasal epinephrine.

Impact

If enacted, HB 156 will amend existing laws to facilitate the availability of emergency medications in schools for students who are asthmatic or at risk of anaphylaxis. It will require schools to stock and provide easy access to these medications to safeguard students’ wellbeing. The legislation is poised to enhance preparedness and appropriate response measures during allergy-related and respiratory medical emergencies, potentially saving lives in critical situations.

Summary

House Bill 156 aims to improve the health and safety of students in Kentucky schools by allowing schools to maintain and utilize injectable or intranasal epinephrine devices and bronchodilator rescue inhalers on their premises. The bill emphasizes the proactive management of anaphylaxis and respiratory distress by ensuring that these critical medications are accessible in various locations within schools. Additionally, the bill encourages schools to implement written individual health care plans for students with life-threatening allergies, ensuring tailored responses to such medical emergencies.

Sentiment

The sentiment surrounding HB 156 appears to be largely supportive, particularly among health professionals and educators who recognize the importance of rapid response to health emergencies in schools. Proponents argue that having these medications readily available can significantly reduce fatalities associated with allergic reactions and asthma attacks. However, there may be concerns regarding the funding and resources needed for schools to implement these measures effectively.

Contention

While the bill has received general approval, discussions indicate some contention around the practical implications of its implementation. Critics might raise issues concerning the adequacy of training for school staff on how to administer these medications and manage situations involving life-threatening allergies. Moreover, there may be debates about liability concerns for schools and their employees when administering emergency medications, which the bill seeks to address by providing certain protections for authorized staff.

Companion Bills

No companion bills found.

Previously Filed As

KY HB384

AN ACT relating to intranasal epinephrine.

KY HB688

AN ACT relating to health care.

KY HB236

AN ACT relating to coverage for epinephrine devices.

KY HB75

AN ACT relating to undesignated glucagon.

KY HB174

AN ACT relating to undesignated glucagon.

KY HB793

AN ACT relating to reproductive health services.

KY HB772

AN ACT relating to pharmaceutical manufacturers.

KY HB389

AN ACT relating to prescription drugs.

KY HB305

AN ACT relating to health care.

KY HB106

AN ACT relating to cannabis.

Similar Bills

No similar bills found.